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Abstract
Chromatin modifications regulate genome function by recruiting protein factors to the genome. 
However, the protein composition at distinct chromatin modifications remains to be fully 
characterized. Here, we use natural protein domains as modular building blocks to develop 
engineered chromatin readers (eCRs) selective for DNA methylation and histone tri-methylation at 
H3K4, H3K9 a H3K27 residues. We first demonstrate their utility as selective chromatin binders 
in living cells by stably expressing eCRs in mouse embryonic stem cells and measuring their 
subnuclear localisation, genomic distribution and histone modification–binding preference. By 
fusing eCRs to the biotin ligase BASU, we establish ChromID, a method for identifying the 
chromatin-dependent protein interactome based on proximity biotinylation, and apply it to distinct 
chromatin modifications in mouse stem cells. Using a synthetic dual-modification reader, we also 
uncover the protein composition at bivalent promoters marked by H3K4me3 and H3K27me3. 
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These results highlight the ability of ChromID to obtain a detailed view of protein interaction 
networks on chromatin.
Chromatin and numerous chemical modifications on histones and DNA play critical roles in 
organismal development and human health1. These modifications are recognised by 
specialised reader domains in regulatory proteins and multiprotein complexes2,3. Depending 
on the presence and composition of modifications at genomic sites, regulatory factors can 
associate with chromatin in a spatiotemporal manner4. However, a major challenge in the 
field remains to understand how this chemical language on chromatin defines the protein 
interactome of the genome.
In recent years, proteomics-based assays helped to measure the affinity of proteins to 
chromatin marks. Current methods probe the cellular proteome using synthetic histone 
peptides, methylated DNA probes or in-vitro-reconstituted nucleosomes5–9. In addition, 
proteins bound to specific genomic segments can be identified using enrichment via 
antibodies, DNA sequence-specific probes or more recently, engineered dCas9-fusion 
proteins10–14. While these studies have greatly enhanced our current knowledge about 
interactions between proteins and chromatin marks, the available methods rely on artificial 
chromatin, protein-protein crosslinking, or methods that require access to the underlying 
DNA, leading to chromatin disruption. Therefore, novel approaches are required that enable 
detection of dynamic interactions between proteins and physiological chromatin in living 
cells.
Here, we developed chromatin-dependent protein identification (ChromID) to identify the 
local protein composition at individual and combinatorial chromatin marks. To this end, we 
used the reader domains of well-established chromatin regulators as modules to build 
engineered chromatin readers (eCRs). We first quantified and functionally validated the 
genome-wide binding and histone-PTM interaction preferences of individual eCRs towards 
DNA methylation, H3K9me3, H3K4me3 and H3K27me3, demonstrating their applicability 
as selective binders in mouse stem cells. Finally, we used the specificity of eCRs to recruit 
promiscuous biotin ligases to detect proteins associated with these individual chromatin 
modifications in mouse embryonic stem cells, revealing similarities and differences in the 
protein composition between these marks. By coupling ChromID to a synthetic dual-
modification reader, we furthermore detected proteins associated with genomic regions 
marked by the bivalent modification H3K4me3 and H3K27me3.
Results
Generation and characterisation of engineered chromatin readers in mouse embryonic 
stem cells
We first assembled well-characterised chromatin reader domains into synthetic reporter 
proteins to test their affinity and specificity for individual chromatin modifications in living 
cells. We used the chromo domains specific for H3K27me3 from CBX7 and Drosophila 
Polycomb (dPC)15,16, the H3K9me3-specific chromodomain from CBX117,18, the Phd 
domain specific for H3K4me3 from TAF319, and the MBD domains from the DNA 
Villaseñor et al. Page 2













methylation readers MBD1 and MeCP220,21 (Fig. 1a). cDNA sequences were assembled 
either as single- or dual-domain constructs into a protein expression cassette containing a 
biotin acceptor site for biochemical purification, a nuclear localisation signal (NLS), and 
eGFP for live imaging and detection (Fig. 1a and Supplementary Fig. 1a). All constructs 
were integrated to a defined site in the mouse genome via Recombinase-Mediated Cassette 
Exchange RMCE22, enabling fast generation of stable mESC lines expressing the proteins 
from the same genomic location and under the control of the same promoter (Fig. 1b). 
Measurements of eGFP fluorescence and protein levels indicated that all generated cell lines 
display stable and homogenous expression of the introduced engineered Chromatin Readers 
(eCR) at intermediate protein levels (Supplementary Fig. 1b-d). We next performed in vitro 
differentiation of mESC to glutamatergic neurons to test if the presence of eCRs interferes 
with biological processes relevant for cellular identity and function. Previous work indicated 
the requirement of the targeted modifications for cellular differentiation23,24. All cell lines 
successfully differentiated to mature neurons, and we could not observe any differentiation 
defects in presence of the eCRs, suggesting that their stable expression does not interfere 
with cellular processes (Supplementary Fig. 1e-g).
Live imaging of stable cell lines with single chromodomain eCRs targeting histone 
methylation showed a diffuse nuclear localisation with accumulation in nucleoli, similar to 
the eGFP control lacking reader domains. In contrast, eCRs containing two chromodomains 
showed a defined pattern with signals for the CBX1-2xChromo eCR at DAPI-dense 
chromocenters and the CBX7- and dPC2-2xChromo eCRs forming discrete subnuclear 
aggregates at the nuclear periphery and around nucleoli (Fig. 1c and Supplementary Fig. 2a). 
These localisation patterns are identical to what has been reported for the subnuclear 
distribution of H3K9me3 and H3K27me3, respectively25,26 (Supplementary Fig. 2b). In 
contrast to the chromodomains, the single and dual TAF3 Phd-domain eCR showed a 
homogenous signal throughout the entire nucleus (Supplementary Fig. 2a) as previously 
reported for H3K4me3 distribution using antibodies26. eCRs containing single MBD 
domains from MBD1 or MeCP2 co-localised with DNA-methylated, DAPI-dense 
chromocenters, similar to their corresponding full-length proteins (Supplementary Fig. 
2a)22. Furthermore, live-cell imaging of the eGFP-tagged eCRs enabled us to explore their 
localisation during cell cycle progression and along the condensed M-phase chromosomes 
(Supplementary Fig. 2c-e and Supplementary Videos).
The results obtained from single and dual-domain eCRs specific for histone modifications 
indicate that one domain is not sufficient to promote localisation and that multivalent 
interactions are required. To further validate this, we made use of reconstituted nucleosomes 
carrying H3K4me3 or H3K27me3 marks on both histone tails. Pulldown experiments using 
recombinant single- or dual-domain eCRs indicate robust interactions only for dual domains, 
but not for single-domain eCRs, supporting the necessity of multivalent interactions for 
stable binding of eCRs to histone-PTMs in vivo (Supplementary Fig. 2f).
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Functional analysis validates the interaction preference of eCRs with specific chromatin 
modifications
Next, we explored the genome-wide binding patterns of all eCRs by biotin-ChIP-seq22. By 
visual inspection of the binding tracks we observed eCR-specific signals corresponding to 
the distribution of target histone modifications and DNA methylation, indicating correct 
localisation to these marks (Fig. 1d-f and Supplementary Fig. 3a-b). Their selective binding 
preference to chromatin modifications was also confirmed by genome-wide enrichments and 
direct comparison to histone modifications, DNA methylation and endogenous reader 
proteins (Fig. 1g, Supplementary Fig. 3c-d and 4a-d). The signals obtained from individual 
eCR datasets indicated their clear distinction in binding to genomic elements modified by 
the corresponding target modifications (Supplementary Fig. 5a-d), where eCRs specific for 
H3K4me3 preferentially associated with gene promoters, H3K9me3 readers with repetitive 
elements, and DNA methylation readers with methyl-CpG-dense exons (Supplementary Fig. 
5e). Notably, and in accordance with live-cell imaging, only experiments using eCRs with 
two histone-PTM reader domains resulted in detectable binding signals (Supplemental Fig. 
3a-b and 5f), highlighting again the necessity for multivalent interactions for stable target 
engagement.
To investigate the specificity of eCRs we introduced mutations to the reader domains known 
to disrupt binding: CBX1-W42A27, CBX7-W35A28, MBD1-R22A29 and furthermore, 
various Rett syndrome mutations in the MeCP2 MBD (R106W, R133C, T158M30) 
(Supplementary Fig. 6a). In all tested instances, we observed that mutations led to a partial 
or complete disruption of subnuclear localisation (Supplementary Fig. 6b), as well as loss of 
genome-wide binding to chromatin modifications (Fig. 2a-b, d and Supplementary Fig. 6c). 
The same disruption of localisation was observed for wild type readers in absence of the 
respective chromatin marks, highlighting that binding is fully dependent on the target 
modification. This dependency was shown by loss of binding of MeCP2-1xMBD in cell 
lines lacking DNA methylation (Dnmt-TKO), and CBX7-2xChromo in cell lines lacking 
H3K27me3 (Eed-KO) (Fig. 2c and Supplementary Fig. 6d-f).
Next, we employed mass spectrometry as an orthogonal approach to identify the histone 
PTMs that are preferentially bound by the eCRs in living cells. Towards this, we detected 
and quantified the modifications on histones enriched in ChIP experiments using a synthetic 
reference peptide library including 87 individual and combined marks on histone tails from 
H2A, H3 and H431 (Supplemental Fig. 7a and b). Overall, the enriched histone PTMs reflect 
the genome-wide correlations described above, further corroborating the specific affinity of 
the reader domains for their substrates in living cells (Fig. 2e). In case of the TAF3-2xPhd 
eCR, we detect histone H3 tails that carry di- and tri- but not mono-methylation marks at the 
lysine 4 residue and furthermore acetylated H3 and H4 (K9, K14 on histone H3 and K5, K8, 
K12, K16 on histone H4) (Fig. 2e-f and Supplementary Fig. 7c). Histone H3 tails containing 
methylated K9, K27 or K36 residues were generally depleted in the TAF3-2xPhd eCR 
pulldowns (Fig. 2e). In contrast, CBX1-2xChromo eCR-enriched histone tails predominantly 
carry the H3K9 tri-methyl mark as well as H4K20me3 (Figure 2e-f), a modification co-
existing with H3K9me3 at repetitive heterochromatin32 (Supplementary Fig. 7d-e). In 
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addition, we also detect that H3S10-phosphorylation prevents binding of the CBX1-eCR to 
H3K9me3, as previously reported for CBX1 in vitro33 (Fig. 2e,g).
Taken together, these experiments validate the target specificity of the introduced eCRs to 
chromatin marks. Furthermore, the obtained results highlight the suitability of eCRs as 
multi-purpose cellular probes to detect the distribution of chromatin modifications in living 
cells by live imaging, genomics and proteomics.
ChromID reveals the protein composition at H3K9- and DNA-methylated sites via eCR-
mediated proximity biotin labelling
Having fully characterised the in vivo binding specificity of eCRs, we wanted to exploit their 
genomic localisation to detect the protein composition at distinct chromatin modifications 
via proximity biotin ligation (Fig. 3a). We tested three different promiscuous biotin ligases 
for their labelling efficiency during 24 hours in murine ES cells: BirA* R118G-mutant34, 
BioID235 and BASU36 (Supplementary Fig. 8a-b). BioID2 and BASU showed the highest 
labelling efficiency under these conditions, therefore we used these ligases in combinations 
with the specific H3K9me3-reader to establish the optimal conditions using quantitative 
label-free LC-MS/MS. The protein interactome of this mark has been well-described in 
mammalian cells5,6, and served as a proof of concept to define optimal settings for ChromID 
(Supplementary Fig. 8c-e and Online Methods). Finally, based on the signal to noise ratio 
we chose BASU with 12 hours biotin-treatment followed by highly stringent washing with 
SDS as the most-optimal condition.
Using these conditions, we identified 58 high-confidence H3K9me3-associated proteins, 
which were enriched for Gene Ontology terms linked to pericentric or telomeric 
heterochromatin, confirming proteins found in other proteomic approaches5,6,37 (Fig. 3b-c, 
Supplementary Fig. 8e and Supplementary Table 1). Found factors include the H3K9 
methyltransferases SETDB1, EHMT1 and EHMT238,39, the HUSH complex component 
MPP840, the chromatin remodeller ATRX41, MeCP2 and UHRF142,43. Besides these factors, 
our method enabled us to identify zinc finger proteins, which have been linked to 
heterochromatin (POGZ, WIZ44,45), and multiple instances that have not been characterised 
in the context of heterochromatin (CASZ1, ZNF24, ZNF292, ZNF512B, ZNF518B, 
ZNF280B and ZNF280D). To test if the newly identified proteins localize to H3K9me3-
marked chromatin, we further validated the localization of the endogenous ZNF280D 
protein. For this, we endogenously tagged ZNF280D in mouse ES cells and performed 
biotin ChIP-seq (Supplementary Fig. 9a-b). Genome-wide binding of ZNF280D shows a 
strong localisation preference to H3K9me3 sites, confirming that ChromID indeed reveals 
proteins associated with specific chromatin marks (Supplementary Fig. 9c-d).
We next used ChromID in conjunction with the 5-methyl-CpG-specific eCR 
(MBD1-1xMBD) resulting in the identification of proteins associated with DNA 
methylation such as DNMT1 and UHRF1 and proteins enriched for Gene Ontology terms 
related to heterochromatin or recognition of DNA replication (Fig. 3d-e, Supplementary Fig. 
10a and Supplementary Table 2). Besides known factors, we also observed several factors 
that have not been associated with DNA methylation in ES cells, such as TIF1A (also known 
as TRIM24), CASZ1, ZNF512B or TEAD1 (Fig. 3d). The latter was recently found to bind 
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to methylated DNA in HT-SELEX experiments46. To test the specificity of these interactions 
for DNA methylation readout, we repeated these experiments using the mutant 5mC-reader 
(MBD1-1xMBD-R22A) fused to BASU. We did not detect any significantly enriched 
proteins with the mutant 5mC-reader, suggesting that the identified proteins associate with 
DNA methylation (Fig. 3d and Supplementary Fig. 10a-c).
Engineered readout of combinatorial histone PTMs enables identification of proteins 
associated with monovalent and bivalent chromatin
Nucleosomes bivalently modified by H3K4me3 and H3K27me3 are found at developmental 
gene promoters and are thought to poise their expression for timely activation47,48. 
Addressing the genomic distribution and/or protein composition of bivalently modified sites 
and other combinatorial modifications has been a major challenge due to lack of tools that 
enable simultaneous detection of both marks. To overcome this limitation, we first 
characterised synthetic readers engineered for simultaneous detection of H3K4me3 and 
H3K27me3 on the same nucleosome. eCRs containing the CBX7-Chromodomain or the 
dPC-Chromodomain fused to the TAF3-Phd domain were stably expressed in ES cells as 
described above (Supplementary Fig. 11a-b). Genome-wide binding analysis indicates 
preferential binding of these bivalent eCRs to genomic sites marked by both H3K4me3 and 
H3K27me3 modifications, while regions containing either H3K4me3 or H3K27me3 were 
not enriched to the same levels (Fig. 4a-c and Supplementary Fig. 11c-e). Monovalent eCRs 
with affinity to H3K4me3 or H3K27me3 only, showed reduced enrichments to bivalent 
regions, while being predominantly recruited to sites modified by H3K4me3 or H3K27me3, 
respectively (Fig. 4a-b and Supplementary Fig. 11c and f). To test the requirement of both 
domains for the observed binding, we introduced mutations in either the TAF3-Phd 
(DW890/891AA19) or the CBX7-Chromo domains (W35A28) of the bivalent reader. We 
observe loss of binding at bivalent sites for both mutant variants (Supplemental Fig. 12a-c). 
To further evaluate the requirement of both histone modifications for recruitment of the 
bivalent readers, we have introduced the TAF3-CBX7-bivalent eCR to Eed-KO ES cells 
lacking H3K27me3. In the absence of H3K27me3, the bivalent reader fails to bind to the 
genome (Supplemental Fig. 12d-e), further supporting the finding that its binding is 
dependent on multivalent readout of both modifications by the two reader domains. Taken 
together, the modular architecture of eCRs opens new possibilities to study and manipulate 
combinatorial modifications in living cells.
The differences in genomic binding observed for the monovalent and bivalent eCRs 
encouraged us to perform ChromID with eCRs specific to H3K4me3, H3K27me3 and 
bivalent nucleosomes. In total, 136 unique proteins that directly or indirectly interact with 
the chromatin marks were found significantly enriched across these three datasets 
(Supplementary Fig. 13a-b, Supplementary Table 1 and 2). A total of 125 proteins were 
detected at H3K4me3 (TAF3-eCR), enriching for GO terms related to transcriptional 
regulation and H3K4me3 (Fig. 5a), including several transcription factors, bromodomain 
proteins, histone modifier and chromatin remodelling complexes, as well as members of the 
Transcription Factor IID (TFIID), Integrator-, Mediator- and Super Elongation-complexes 
(Supplementary Fig. 13a-b and Supplementary Table 1). Notably, we also detect proteins 
involved in co-transcriptional processes such as the RNA-specific adenosine deaminase 
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ADAR1 and the histone mRNA 3' end processing factor CASP8AP2/FLASH49 to be 
associated with H3K4me3, which we confirmed by comparing genomic co-localisation of 
FLASH and H3K4me3 at transcribed histone genes (Fig. 5b).
The H3K27me3-reader enabled us to identify 20 high-confidence hits, enriching for GO 
terms associated with Polycomb repressive complexes and histone methyltransferases (Fig. 
5a, Supplementary Fig. 13a-b and Supplementary Table 1). Among those hits we observed 
well-studied subunits of PRC1 and PRC2 (RING2, EZH2, MTF2 and JARD2). Notably, we 
also identified factors involved in H3K9 methylation like SETDB1 or the zinc finger 
proteins WIZ and ZNF518B, suggesting a potential crosstalk between proteins bound at 
H3K9me3 and H3K27me3 sites. Notably, this is not due to unspecific localisation of the 
H3K27me3 readers to H3K9me3 or vice versa, since we do not observe this cross-reactivity 
from our ChIP-seq data (Supplementary Fig. 13c). Furthermore, by performing ChromID 
with the H3K27me3-specific readers in ES cells lacking H3K27me3 (Eed-KO), we would 
expect that such unspecific interactions would persist. However, we fail to detect any 
enriched proteins, indicating that the reported interactions indeed originate from H3K27me3 
sites (Supplementary Fig. 13d).
Finally, the combinatorial recognition of bivalent H3K4me3 and H3K27me3 loci by the 
CBX7-TAF3-eCR enabled us to discover 33 high-confidence factors associated with bivalent 
chromatin, enriched in GO terms related to transcriptional activation and repression (Fig. 5a, 
Supplementary Fig. 13a-b and Supplementary Table 1). These included catalytic subunits or 
components of the MLL1/MLL2, the NSL histone acetyltransferase and the TFIID basal 
transcription factor complex, although TFIID components were detected at lower levels 
compared to results obtained with the monovalent H3K4me3 reader. Other factors include 
enhancer of Polycomb homolog (EPC1 and EPC2) and components of the NuA4 histone 
acetyltransferase (HAT) complex50. Corroborating our findings, a recent study mapped the 
catalytic subunit of the NuA4 complex (TIP60) to bivalent regions in mouse ES cells51. We 
also identified the histone lysine 9 and 36 demethylase KDM4C/JMJD2C52 that colocalises 
with EZH2 in mouse ES cells53, and PHF8, a demethylase involved in removal of 
H3K9me2, H3K27me2 and H4K20me1-residues54. Among the core components of the 
PRC1 and PRC2 complexes, we also detected BCOR, MGAP and LMBL2 which are part of 
the alternative PRC1.1 and PRC1.6 complexes55. Notably, we also observe the 
methylcytosine dioxygenase TET1 and the transcriptional repressor SIN3A being associated 
to bivalent sites, in line with previous genomic studies showing TET1 and SIN3A at bivalent 
promoters in ES cells56. Finally, we introduced the bivalent reader in ES cells lacking 
H3K27me3 and performed ChromID to control for false-positive proteins stemming from 
unspecific interactions of the readers with marks outside of nucleosomes modified by 
H3K27me3 and H3K4me3. In this case we could not identify any significantly enriched 
proteins, indicating that the reported proteins are indeed localised to bivalently-modified 
regions in the genome (Supplementary Fig. 13e).
To exclude that the BASU biotin ligase could influence genomic localisation of the readers 
and therefore falsely report proteins from sites not decorated by the targeted modifications, 
we performed biotin-ChIP-seq of the eCR-BASU constructs and compared their binding to 
the previously-obtained datasets of eGFP-fusion constructs (Supplementary Fig. 14a-c). 
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Based on our genome-wide analysis, binding was highly correlated between the same 
readers fused to either eGFP or BASU, indicating that the reader domains are not influenced 
by the addition of the biotin ligase. In summary, these results highlight the applicability of 
modular eCRs as a platform for biotin ligase recruitment, enabling successful identification 
of the associated proteins of chromatin subtypes.
Integrative analysis of ChromID datasets reveals the chromatin preference of regulatory 
proteins
Based on the combined datasets from all ChromID experiments we investigated the 
distribution of proteins between the different chromatin states, revealing proteins shared 
between multiple chromatin states, and proteins specific to single chromatin modifications. 
The latter was most prominent for H3K4me3-associated proteins (Fig. 5c, Supplementary 
Fig. 15a). Notably, several proteins identified at H3K27me3 or bivalent regions were also 
associated with H3K4me3, which is expected given the overlap of these modifications in ES 
cells47. In addition, we found multiple proteins shared between H3K9me3 and H3K27me3, 
while little overlap was found between the H3K9me3 set and proteins detected by H3K4me3 
or bivalent regions (Fig. 5c and Supplementary Fig. 15a). Given the well-established 
crosstalk between DNA methylation and H3K9me3, we identified a substantial overlap 
between these sets (Supplementary Fig. 15b). The functional relationship of the detected 
factors was further visualised from high-confidence interaction scores obtained from the 
STRING database, revealing a strong interconnectivity between proteins and complexes 
associated with H3K4me3 and bivalent regions or with heterochromatin marked by 
H3K9me3 or H3K27me3 (Fig. 5d).
To obtain a quantitative view on the distribution of regulatory proteins along the interrogated 
chromatin marks, we clustered factors from different regulatory groups based on their 
enrichment across all datasets (Fig. 5e). For transcription factors, we observed several 
associations with H3K4me3 regions (e.g. SP2, MAX, FOXK2, ZFX). In addition, several 
TFs, mainly uncharacterised ZNF proteins, are associated with DNA methylation 
(ZNF280B, ZNF292, ZNF462, CASZ1, TCF20) and we also recover TFs previously 
identified to interact with methylated DNA in pull-down or HT-SELEX assays (KLF4, 
RREB1, ZNF191/24)9,46 (Fig. 5e). Similar to TFs, chromatin remodellers separate into a 
group predominantly associated with H3K4me3 (e.g. BRD2, BRD4, INO80, CECR2), and a 
group preferentially associated with closed chromatin (e.g. ATRX, BAZ2A, SMARCA1). 
Chromatin writers such as H3K4-specific methyltransferases (KMT2A, KMT2B) and 
histone acetyltransferases (EP300) were preferentially located at H3K4me3, while writers of 
repressive marks associated with DNA methylation, H3K9me3 and/or H3K27me3 (DNMT1, 
EHMT1/2, NSD1, EZH2). Furthermore, and in line with genome-wide binding data, erasers 
such as KDM2A, KDM2B, TET1 or KDM5A were predominantly found at H3K4me3 sites, 
and we find several DNA repair factors associated with repressive chromatin marks (Fig. 
5e). Taken together, these datasets obtained by ChromID provide a valuable resource of 
chromatin-mediated protein interactions in the ES cell genome.
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Here we present ChromID, a quantitative approach that enables identification of proteins 
associated with individual and combinatorial chromatin modifications in living cells. 
ChromID takes advantage of the affinity of engineered chromatin readers, which we 
obtained from natural reader domains of well-characterised chromatin regulators (CBX1, 
CBX7, dPC, TAF3, MBD1 and MeCP2). First, we characterised and functionally validated 
the binding selectivity of all eCRs using a series of quantitative and functional methods in 
mouse ES cells. The obtained results highlight the applicability of eCRs as an alternative to 
antibodies for studying subnuclear localisation, genome-wide distribution and histone-PTM 
combinations in living cells. Single domain eCRs were often insufficient to achieve binding 
to histone modifications under physiological conditions. This is in line with several well-
known examples where binding of full-length proteins or complexes to chromatin rely on 
multivalent interactions4, including recent studies that introduced synthetic multivalent 
chromatin readers for immunofluorescence or activation of reporter genes57–59. We made 
use of the required multivalent interactions to generate synthetic readers that recognise two 
modifications on the same nucleosome. Here, a short NLS was sufficient as a linker between 
the two reader domains, since our dual-reader eCRs target modifications on two different 
histone tails. This allowed us to directly target genomic sites that are bivalently marked by 
H3K4me3 and H3K27me3, providing novel tools to study and manipulate chromatin 
modifications in a context-dependent manner.
Finally, to identify the chromatin-associated protein interactome, we developed ChromID 
where we use the eCRs to tether promiscuous biotin ligases to chromatin, resulting in 
biotinylation of proteins in a ~ 35 nm radius around the modification of interest. This 
allowed us to detect proteins that directly and indirectly associate with chromatin 
modifications including DNA methylation, H3K4me3, H3K27me3 and H3K9me3, resulting 
in a total of 518 identified proteins. Among these we identified 180 high-confidence proteins 
enriched across all datasets, enabling us to assign factors based on their preference towards 
single or multiple chromatin marks. By employing the bivalent reader, we further achieved 
specific identification of proteins bound at sites marked by H3K4me3 and H3K27me3, 
revealing the presence of activating and repressing proteins from Trithorax and Polycomb 
complexes and additional factors that could play a role in chromatin regulation at bivalent 
sites.
Overall, the results from the individual and combinatorial measurements highlight ChromID 
as an approach to uncover how protein recruitment is influenced by chromatin modifications 
in living cells. The usage of natural reader domains in ChromID mimics physiological 
engagement of proteins with chromatin. This has several benefits, since the eCR-mediated 
interactions do not require crosslinking or single-stranded DNA. Another benefit of 
ChromID is the usage of proximity biotin ligation to label and subsequently identify the 
proteins associated with different chromatin flavours in a unified manner. This enables 
comparative studies between different chromatin modifications, circumventing the necessity 
of antibodies, which have always been limiting in such assays due to their variation in 
affinity and avidity, lack of availability and cost. Furthermore, once biotinylated, the proteins 
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are enriched using highly-stringent washing and elution conditions, ensuring effective 
removal of background signals and reproducible detection and multi-sample comparison.
We expect ChromID to be used to chart the protein interactome at multiple chromatin 
modifications and in numerous cell types in order to understand how the chemical language 
on chromatin directs protein recruitment in a spatiotemporal manner. The applicability of 
ChromID in living cells, as well as eCRs as synthetic readers, further opens the possibility to 
perform similar experiments in a tissue-specific manner in living animals to chart the epi-
proteome during dynamic cellular processes and development.
Online Methods
Molecular cloning
Reader domains were amplified from cDNA or synthesized (IDT technologies) based on 
available domain annotations (Uniprot). Coding sequences are introduced in-frame to the 
RMCE-targeting vector parbit-v6 by Gibson assembly. The final construct expresses the N-
terminal biotin-tagged domain of interest fused in-frame to a cassette containing an NLS 
signal followed by eGFP, an internal ribosome entry site (IRES) and the puromycin-N-
acetyltransferase gene. All coding sequences are under control of a constitutive CAG 
promoter. BioID2-HA and the 13X-Linker were PCR amplified from MCS-13X-Linker-
BioID2-HA plasmid (addgene #80899), HA-BASU was PCR amplified from BASU-RaPID 
plasmid (kindly provided by P. Khavari; equivalent to Addgene #107250). PCR-amplified 
products were cloned into RMCE-targeting vector L1-CAG-NLS-IRES-pac-1L (parbit-v9) 
by Gibson assembly. For bacterial expression of eCR-eGFP-6xHis fusion proteins, 
sequences spanning the domains of interest along with the NLS and eGFP were PCR 
amplified from parbit-v6 and subcloned into a modified pET-28 vector encoding an in-frame 
C-terminal 6xHis affinity tag.
Cell culture and cell line generation
Mouse embryonic stem cells (HA36CB1, 129×C57BL/6) were cultured as previously 
described22. Cell lines were obtained by recombinase-mediated cassette exchange (RMCE). 
Briefly, RMCE constructs were co-transfected with a CRE recombinase expression plasmid 
(1: 0.6 μg DNA ratio) to RMCE-competent and biotin ligase (BirA)-positive mouse ES cell 
lines (HA36CB1)22. Two rounds of selection were applied to yield a homogenous 
population of eCR expressing cells: 3mM ganciclovir for 4 days and 2mM puromycin for 2 
days. Homogenous and stable protein expression was then monitored by eGFP expression 
using flow cytometry, immunofluorescence (IF) and immunoblotting. Transfections were 
carried out using Lipofectamine 3000 reagent (Thermo Fisher Scientific, L3000015) at a 2:1 
μg DNA ratio in OptiMEM medium (Thermo Fisher Scientific, 31985070). The Eed-KO cell 
line was generated by co-transfecting pX330-U6-Chimeric_BB-CBh-hSpCas9 (addgene 
#42230) with a guide (GGTGAAAAAATAATGTCCTG) targeting exon 8 together with 
pRR-Puro recombination-reporter60 (addgene #65853). 36 hours after transfection, cells 
were treated with 2 ug/ml puromycin for 36 h. Positive KO clones were validated by Sanger 
sequencing and Western blot. Endogenously tagged Zfp280D cell line was generated with a 
guide (AGTAGACCTGGCAGATGGAG) targeting exon 22 and co-transfecting pRR-EGFP 
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recombination-reporter (addgene #6585260). 72 hours after transfection, single GFP-positive 
cells were sorted by flow cytometry and validated by Sanger sequencing. Neuronal 
differentiation of ES cells was performed as previously described61.
Flow cytometry
Cells were resuspended in DPBS and incubated with LIVE/DEADTM Fixable Near-IR 
Dead Cell Stain (Invitrogen, L34975) to discriminate cell viability. Samples were analysed 
on a FACSCanto (BD Biosciences). Cells were gated for viable and individual cells, channel 
voltages for eGFP (Alexa Fluor 488-A) and live/dead (APC-Cy7A) signals were set 
regarding verified negative and positive eGFP-expressing control cells. Raw files were 
analysed and visualised using FlowJo software (Tree Star; version 10.0.7). For CD24 
measurements in neuronal progenitors, single cell suspensions were obtained from neuronal 
progenitors after 8 days of differentiation as previously described61. For cell surface staining 
cells were incubated for 30 min at 4°C with saturating concentration of anti-CD24a 
monoclonal antibody in the presence of anti-CD16/CD32 (eBioscience). Samples were 
acquired using FACSFortessa (BD Biosciences) and data were analysed using FlowJo 
software (Tree Star).
Western blotting
For eCR detection, 20 μg of protein were resolved in NuPAGE-Novex Bis-Tris 4–12% 
gradient gels (Invitrogen) and transferred on polyvinylidene fluoride (PVDF). Membranes 
were blocked with 5% (w/v) BSA in TBST (10mM Tris pH 8.0, 150mM NaCl, and 0.1% 
Tween-20), and stained with the corresponding primary antibody anti-HP1b/CBX1 (1:1,000, 
CST; #8676) or Lamin B1 (1:1000, Santa Cruz, sc-374015) at 4°C overnight, followed by 
detection with species-specific horseradish peroxidase (HRP)-conjugated secondary 
antibodies. For validation of Eed-KO cell lines, cells were lysed with NETN buffer (20 mM 
Tris (pH 8), 0.5 % (v/v) NP-40, 100 mM NaCl, 1 mM EDTA (pH 8)) supplemented with 1 x 
protease inhibitor cocktail (Roche; COEDTAF-RO) and 1 mM DTT (Sigma Aldrich, DTT-
RO). Nuclei were pelleted at 6,500 x g for 10 min at 4 °C, washed once with NETN. 
Histones were acid-extracted overnight at 4 °C in 0.2 N HCl at a density of 4 x 10^7 nuclei 
per ml. Histone extracts were then centrifuged at 6,500 x g for 10 min at 4 °C to pellet debris 
and 5 ug were loaded onto a NuPAGE-Novex 16% Tris-Glycine Gel (Invitrogen). Western 
Blot and protein detection were performed as above with a transfer buffer containing no 
SDS, but 20 % MeOH, and membrane was stained with primary antibody anti-H3K27me3 
(Diagenode, C15410195), anti-Histone H1 (Millipore, 05-457) and anti-Histone H3 (Abcam, 
ab1791).
Live-cell imaging and image processing
2x 10^4 eCR-eGFP fusion expressing cells were seeded on 0.2% gelatin-coated 35-mm 
chambered coverslip (Ibidi; 80826) one day before imaging. Next day, cells were stained 
with Hoechst 33342 (Invitrogen; 62249) for 10 min, washed twice with DPBS, and covered 
with ES cell medium containing DMEM w/o phenol red (Invitrogen, 31053028). Randomly 
selected cells were imaged with sequential acquisition settings on a Leica SP5 inverted 
confocal laser scanning microscope equipped with a climate chamber, an Argon laser for 
453, 476, 488, 496, and 514 nm, and a diode laser for 561 nm. Filters for fluorescence 
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imaging were GFP (ex BP 470/40, em BP 525/50) and N3 (ex BP 546/12, 600/400). 
Confocal images were acquired with an HCX PL APO Leica 63× oil immersion objective 
with HyD detectors. Z stacks were acquired per site using a 0.3 μm step size. Time-lapse 
fluorescence microscopy was performed with a confocal spinning disk imaging system 
(Olympus IXplore SpinSR10,) equipped with a CSU-W1 unit (YOKOGAWA) and a 60× 
UPLSAPO UPlan S Apo silicon oil objective of 1.3 NA (Olympus Corporation). 11 z planes 
were acquired per site (1μm step size) every 5 min for approximately 12.5 hours. A 488nm 
laser was used to excite the GFP probe while emitted light was filtered by a 525/50 band 
pass filter and captured by a Prime BSI Scientific CMOS camera (2048 × 2048 pixels, 
Teledyne Photometrics). Images were deconvolved using Huygens Professional 19.10 
software (Scientific Volume Imaging) using up to 40 iterations of the Classic Maximum 
Likelihood Estimation algorithm with a theoretical PSF. Background correction was 
automatic. The signal-to-noise ratio setting was adjusted empirically to 16 to give 
satisfactory results. Image analysis was performed on the resulting image series using FIJI 
(version 2.0.0) and the Bio-Formats Importer plugin. Appropriate single z-planes were then 
selected for further image analysis and display.
Fixed-cell immunofluorescence
Cells were seeded and grown as described above, fixed in 4% formaldehyde in PBS for 10 
min at room temperature, washed three times in PBS, permeabilized for 5 min at room 
temperature in PBS supplemented with 0.1% Triton X-100 and 0.25% BSA (Sigma-
Aldrich), and washed twice in PBS. Corresponding primary antibodies anti-H3K9me3: 
ab8898 (abcam), anti-H3K27me3: C15410195 (diagenode), anti-GFP: 11814460001 
(Millipore) and secondary antibodies (Alexa Fluor 488 anti-mouse and 568 anti-rabbit IgGs 
from ThermoFisher) were diluted in PBS containing 2% FBS and 0.02% BSA. Primary 
antibody incubations were performed overnight at 4°C. Secondary antibody incubations 
were performed for 1h at room temperature. Following antibody incubations, cells were 
washed once with PBS and incubated for 10 min with PBS containing 4’,6-diamidino-2-
phenylindole dihydrochloride (DAPI, 0.5 μg/ml) for 10 min at room temperature to stain 
DNA. Randomly selected cells were imaged with sequential acquisition settings on a Leica 
SP5 inverted confocal laser scanning microscope.
Generation of recombinant nucleosomes
Core histones (Xenopus H3 and H4, human H2A and H2B) and truncated histone H3 for 
native chemical ligation (NCL) were expressed in E. coli and purified as previously 
described48,62. NCL reactions to generate H3K4me3, H3K4me1, and H3K9me3-modified 
histone H3 were carried out as described 62 with truncated H3 lacking residues 1-31 after the 
initiator methionine and containing a threonine-to-cysteine substitution at position 32 and a 
cysteine-to-alanine substitution at position 110 (H3Δ1–31 MT32C C110A) and the 
corresponding synthetic thioester peptide spanning residues 1–31 of histone H3.1 and 
containing the desired modification (Peptide Protein Research Ltd., Fareham, UK). For 
generation of H3K27me3-modified histones, a similarly truncated Xenopus H3 construct 
was used, lacking the first 44 residues and carrying a threonine-to-cysteine mutation at 
residue 45 (H3Δ1–45 MT45C C110A). Histone octamers were assembled and reconstituted 
into mononuclesomes carrying 601 DNA as described48.
Villaseñor et al. Page 12













Bacterial expression of eCR-eGFP-His fusion proteins
His-tagged eCR-eGFP fusion proteins were expressed in BL21 (DE3) E. coli by induction 
for 3 h at 37°C with 0.5 mM IPTG in the presence of 20 μM ZnCl2. Cells were lysed by 
sonication in lysis buffer (20 mM Tris HCl pH 8, 500 mM NaCl, 0.1% NP-40, 0.5 mM 
PMSF). His tagged protein was bound to Sepharose 6 Fast Flow Ni-NTA resin (GE 
Healthcare), washed with 300 mM wash buffer (50 mM NaH2PO4 pH 8, 300 mM NaCl, 20 
mM imidazole, 0.1 mM PMSF) and 1 M wash buffer (1 M instead of 300 mM NaCl), and 
eluted in 50 mM NaH2PO4 pH 8, 300 mM NaCl, 250 mM imidazole. Fractions containing 
the desired eCR-eGFP fusion protein were pooled and dialysed against BC100 (20 mM 
HEPES KOH pH 8, 100 mM KCl, 10% glycerol, 0.5 mM DTT).
Nucleosome pulldown assays
For pulldown assays with recombinant modified nucleosomes and eCR-eGFP fusion 
proteins, streptavidin sepharose high performance beads (GE Healthcare) were blocked with 
1 mg/ml BSA in pulldown buffer (20 mM HEPES KOH pH 7.9, 150 mM NaCl, 10% 
glycerol, 1 mM EDTA, 1 mM DTT, 0.2 mM PMSF, 0.1% NP-40, 0.1 mg/ml BSA) before 
three washes with pulldown buffer. All centrifugation steps were carried out at 1,500 g for 2 
min at 4°C. All incubation steps were carried out at 4°C. Beads were incubated overnight 
with 3 μg of assembled recombinant nucleosomes in pulldown buffer. After three washes, 
bead-bound nucleosomes were incubated with increasing amounts of eCR-eGFP fusion 
proteins for 2 h. Beads were then six times washed with pulldown buffer by 5-min 
incubation under rotation before elution of bound proteins by boiling with 1.5x SDS sample 
buffer (95 mM Tris HCl pH 6.8, 15% glycerol, 3% SDS, 75 mM DTT, 0.15% bromophenol 
blue). Protein binding was analysed by Western Blotting with anti-His antibody (Sigma, 
H10229), and corresponding histone modification antibodies.
Chromatin immunoprecipitation sequencing
For cross-linking and chromatin extraction, 30–50 × 10^6 cells were fixed for 8 min with 
1% formaldehyde at room temperature followed by the addition of glycine (final 
concentration 0.12 M) and incubation for 10 min on ice. Cell lysis, chromatin extraction and 
fractionation, followed by antibody or streptavidin-based enrichment was performed as 
previously described63. For biotin-ChIP we used 90 μl pre-blocked streptavidin-M280 per 
150–200 μg chromatin, for antibody-ChIP we used 5 ug of antibody for 100 μg chromatin. 
Antibodies used: H3K27me3 (Diagenode, C15410195), H3K4me3 (abcam, ab8580), 
H3K9me3 (abcam, ab8898). ChIP-seq libraries were prepared using the NEB-next ChIP-seq 
library Kit (E6240) following the standard protocols. Up to 8 samples with different index 
barcodes were combined at equal molar ratios and sequenced as pools. Sequencing of library 
pools was performed on Illumina HiSeq 4000 or Nova Seq machines according to Illumina 
standards, with 75- to 150-bp single-end sequencing. Library demultiplexing was performed 
following Illumina standards.
Genomics data analysis
Sequencing samples were filtered for low-quality reads and adaptor sequences removed 
using Trim Galore (https://github.com/FelixKrueger/TrimGalore). Filtered reads were 
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mapped using QuasR64 in R to the mouse genome (version mm9) using the BOWTIE 
algorithm allowing for two mismatches and only unique mappers were used (-m 1 --best --
strata). Identical reads from PCR duplicates were filtered out.
To obtain genome-wide 1kb intervals, we partitioned the entire genome into 1 kb sized tiles. 
Intervals overlapping with satellite repeats (Repeatmasker), ENCODE black-listed and low 
mappability scores65 (below 0.5) were removed in order to reduce artefacts due to 
annotation errors and repetitiveness. To detect eCR-enriched regions, we utilised MACS2 
using the eGFP ChIP-seq as background and applying the following parameters: --broad -g 
mm --broad-cutoff 0.1. To detect antibody-specific peaks for histone modifications, we 
applied the same approach but using input chromatin as a background signal. Obtained 
histone modification peaks were further filtered according to qval >= 2 and pileup >= 3.4 
scores. Peaks were overlapped with genomic features and coverages were calculated using 
the following hierarchy: promoters, enhancers, exons, repeats and introns. Promoters were 
defined as +/- 1kb around RefSeq gene TSS, enhancers were defined based on DHS peaks 
where H3K4me1 was higher than H3K4me366, exons and introns were retrieved based on 
RefSeq annotations, and repetitive elements using Repeatmasker. ChromHMM 
segmentation67 of the mouse genome was obtained from http://compbio.mit.edu/
ChromHMM/, as part of ENCODE. For Figure 1e, a genomic range object containing all 
peaks was generated, overlapping peak regions were merged, and finally used to compute 
correlations between eCR and antibody signals. To define H3K4me3-monovalent, 
H3K27me3-monovalent and bivalently-marked peaks, we calculated the H3K4me3 and 
H3K27me3 enrichments at these sites and selected all H3K4me3 peaks devoid of 
H3K27me3 as H3K4me3-monovalent peaks. H3K27me3 lacking H3K4me3 signals were 
selected as H3K27me3-monovalwent while H3K4me3 peaks positive for H3K27me3 were 
selected as bivalent peaks. ChIP enrichments at genomic segments and peaks were 
calculated as log2-fold changes over input chromatin (for antibodies) and over eGFP (for 
eCRs) after library size normalization and using a constant of eight pseudo counts to reduce 
sampling noise. Heatmap and average density-profiles around peaks were generated using 
genomation in R68.
Mass spectrometry analysis of histone modifications
Histones were processed as described in31,69 with modifications as described below. De-
crosslinked histones were separated by SDS-PAGE on 16 % Novex Tris-Glycine gels 
(Invitrogen, XP00165BOX), stained with InstantBlue (Expedeon, ISB1L) and bands 
corresponding to core histones were excised. Gel pieces were washed twice with water and 
twice with 100 mM ammonium bicarbonate. Gel pieces were destained by incubating three 
times for each 10 min with 50 mM ammonium bicarbonate/50% acetonitrile at 37 °C with 
shaking at 800 rpm in a Thermomixer. Gel pieces were successively dehydrated by 
incubating with 100 mM ammonium bicarbonate, once 20 mM ammonium bicarbonate and 
three times with acetonitrile. Histones were twice derivatized by chemical acetylation by 
reacting 5 μL of d6-acetic anhydride ((CD3CO)2O, Sigma-Aldrich), 15 μL of 100 mM 
ammonium bicarbonate and 1 M ammonium bicarbonate buffered with 1:2 diluted 
ammonium hydroxide solution to keep the pH at 8. The reactions were performed for 45 min 
at 37 °C with shaking at 800 rpm in a Thermomixer. After the derivatization reactions, 
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histones were washed four times with 100 mM ammonium bicarbonate, two times with 
water, and three times with acetonitrile. Histone gel pieces were rehydrated with a 25 ng/ul 
trypsin solution in 100 mM ammonium bicarbonate (sequencing-grade trypsin from 
Promega) and digested overnight at 37 °C. Processing of tryptic peptides, mass 
spectrometric measurements and data analysis as previously described69.
Nuclear extraction for ChromID
Cells were cultured with ES medium and induced for the corresponding time periods (12-24 
hours) with 50μM biotin (Sigma) dissolved in DPBS. Cells were grown to about 90% 
confluency on 15cm dishes (approximately 50 x 10^6 cells), harvested by trypsinisation, and 
pelleted by centrifugation at 1000 rpm for 5 min. The subsequent steps were either 
performed on ice or at 4°C. Pellets were gently resuspended (by shaking) in 5 pellet volumes 
(PV) of nuclear extract buffer 1 (NEB1; 10mM HEPES pH7.5, 10mM KCl, 1mM EDTA, 
1.5mM MgCl2, 1mM dithiothreitol (DTT), and 1x PIC) and swelled on ice for 10 min, 
followed by centrifugation at 2000 g for 10 min. Pellets were then gently resuspended in 2x 
PV of NEB1, followed by dounce homogenisation using a loose pistil (10 times up and 
down). Nuclei were collected by centrifugation at 2000 g for 10 min and resuspended in 1x 
PV of NEB1 + 12μl/ml of Benzonase (Millipore, 71206) to digest genomic DNA, followed 
by overhead rotation at 4°C for 3 hours. Nuclei were then pelleted by centrifugation at 2000 
g for 10 min, resuspended in 1x PV of NEB2-450 (20mM HEPES pH 7.5, 0.2mM EDTA, 
1.5mM MgCl2, 20% glycerol, 450mM NaCl, 1mM DTT, and 1x PIC), Dounce 
homogenised using a tight pistil (10 times up and down), vortexed, followed by overhead 
rotation at 4°C for one hour. Cell debris were removed by centrifugation at 2000 g for 10 
min. The salt concentration of the nuclear extracts (NE) was adjusted to 150mM by drop-
wise addition of 2x residual volume of NEB2-NS (see above, without NaCl), and NP40 
levels were adjusted to 0.3%. Subsequently, protein concentrations were measured using 
QubitTM Protein Assay Kit (Thermo Fisher Scientific, Q33211). Equal amounts of proteins 
were used per IP (standard: 2 mg) and protein lysate volumes were adjusted to equal 
volumes with IP buffer (IPB; NEB2-150, 0.3% NP40, 1mM DTT, and 1x PIC).
Streptavidin beads preparation for affinity purification
Streptavidin M-280 Dynabeads (Thermo Fisher) were equilibrated three times with IPB (see 
above) by overhead rotation for 10 min at 4°C and subsequently pre-blocked in IPB + 1% 
cold fish gelatin rotating 4°C for 1 hour. Finally, beads were taken up in IPB (starting 
volume). 40 μl of pre-blocked Streptavidin M-280 beads were added to lysates and 
incubated overnight rotating at 4°C.
High stringency washes and on-bead digestion for ChromID
After incubation of nuclear lysates with beads rotating at 4°C overnight, beads were 
separated from the unbound fraction on a magnetic rack and washed twice with 2% SDS in 
TE (+ 1mM DTT, 1x PIC) for 10 min rotating overhead at room temperature (RT), once with 
high salt buffer (HSB; 50mM HEPES pH 7.5, 1mM EDTA, 1% Triton X-100, 0.1% 
deoxycholate, 0.1% SDS, 500mM NaCl, 1mM DTT, and 1x PIC) for 10 min at RT, once 
with DOC buffer (250mM LiCl, 10mM Tris pH 8.0, 0.5% NP40, 0.5% deoxycholate, 1mM 
EDTA, 1mM DTT, and 1x PIC) for 10 min at 4°C, and twice with TE buffer (+ 1mM DTT, 
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1x PIC) for 10 min at 4°C. After the washes, beads were isolated from the last TE wash on a 
magnetic rack and the proteins were digested with 0.5 μg trypsin (Promega; V5111) in 40ul 
digestion buffer (1M Urea in 50mM Tris pH 8.0, 1mM Tris-(2-carboxyethyl)-phosphin 
(TCEP)) directly on beads, overnight at 26°C and shaking at 600 rpm. Next day, the digested 
protein-peptide mix was isolated from beads and reduced with 2mM TCEP for 45 minutes at 
RT, and then alkylated with 10mM Chloroacetamide (ClAA) for 30min at RT in the dark. 
The digestion was stopped by acidifying the peptides with Trifluoracetic acid (TFA) to a 
final concentration of 0.5%, and the acetonitrile (ACN) concentration was adjusted to 3% 
prior loading on C18 StageTips.
C18 StageTips clean-up
Obtained peptides were cleaned-up using in-house produced (Functional Genomics Center 
Zurich, FGCZ) C18-StageTips. StageTips were humidified with 100% methanol (MeOH), 
cleaned twice with 60% ACN; 0.1% TFA, and conditioned twice with 3% ACN; 0.1% TFA. 
Peptides were loaded onto the StageTips, and the collected flow-through was loaded again. 
Afterwards, the peptides were desalted twice with 3% ACN; 0.1% TFA, and finally eluted 
twice with 60% ACN; 0.1% TFA. Desalted peptides were shock frozen in liquid nitrogen 
(N2), completely dried in a speed vacuum centrifuge, and subsequently resolved in 3% 
ACN; 0.1% formic acid (FA), containing internal retention time standard peptides (iRT Kit 
Ki-3002-1, Biognosys).
Detection of biotinylated proteins by data-dependent acquisition (DDA) mass spectrometry
We used an Easy-nLC 1000 HPLC system operating in trap / elute mode (trap column: 
Acclaim PepMap 100 C18, 3um, 100A, 0.075x20mm; separation column: EASY-Spray C18, 
C18, 2um, 100A, 0.075x500mm, Temp: 50°C) coupled to an Orbitrap Fusion mass 
spectrometer (Thermo Scientific). Trap and separation column were equilibrated with 12 ul 
and 6 ul solvent A (0.1 % FA in water), respectively. 2 μl of the resuspended sample solution 
was injected onto the trap column at constant pressure (500 bar) and peptides were eluted 
with a flow rate of 0.3 μl/min using the following gradient: 2 % - 25 % B (0.1 % FA in 
ACN) in 50 min, 25 % - 32 % B in 10 min an 32 % - 97 % B in 10 min. After 10 min of 
washing by 97 % B. High accuracy mass spectra were acquired with an Orbitrap Fusion 
mass spectrometer (Thermo Scientific) using the following parameter: scan range of 
300-1500 m/z, AGC-target of 4e5, resolution of 120’000 (at m/z 200), and a maximum 
injection time of 50 ms. Data-dependent MS/MS spectra were recorded in top speed mode in 
the linear ion trap using quadrupole isolation (1.6 m/z window), AGC target of 1e4, 300 ms 
maximum injection time, HCD-fragmentation with 30 % collision energy, a maximum cycle 
time of 3 sec, and all available parallelizable time was enabled. Mono isotopic precursor 
signals were selected for MS/MS with charge states between 2 and 7 and a minimum signal 
intensity of 5e3. Dynamic exclusion was set to 25 sec and an exclusion window of 10 ppm. 
After data collection, the peak lists were generated using automated rule-based converter 
control70 and Proteome Discoverer 2.1 (Thermo Scientific).
Protein identification and label-free protein quantification of DDA data
Raw data were processed with MaxQuant (version 1.5.3.30) and its built-in Andromeda 
search engine for feature extraction, peptide identification and protein inference71. The 
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mouse reference proteome (UniProtKB/Swiss-Prot and UniProtKB/TrEMBL) version 
2018_12 combined with manually annotated contaminant proteins was searched with protein 
and peptide false discovery rates (FDR) values set to 1%. Match-between-runs algorithm 
was enabled. All MaxQuant parameters can be found in the uploaded parameterfile: 
rpx40_mqpar.xml (deposited in the PRIDE repository). Perseus (versions 1.6.1.1) was used 
for statistical analysis72. Results were filtered to remove reverse hits and proteins only 
identified by site. Further, only proteins found in at least 3 replicates were kept. Missing 
values were imputed from a 1.8 standard deviations left-shifted Gaussian distribution with a 
width of 0.3 (relative to the standard deviation of measured values). Potential interactors 
were determined using a two sample t-test using s0 = 0.1 and 1 (details shown in volcano 
plots) and permutation-based FDR = 0.0173 and visualised by volcano plots. Obtained 
results were exported and further visualised using the statistical computer language R 
(version 3.5.2).
Estimation of protein abundance by data-independent acquisition (DIA)
Cells were grown to about 90% confluency on 10 cm dishes (approximately 15 x 10^6 
cells), harvested by trypsinisation, and pelleted by centrifugation at 1000 rpm for 5 min. Cell 
nuclei were extracted following the nuclear extraction procedure (described above) until 
digestion of genomic DNA. Nuclei were then pelleted by centrifugation at 2000 g for 10 min 
and resuspended in 30 μl lysis buffer (4% (w/v) SDS, 100 mM Tris/HCL pH 8.2). Lysate 
was incubated at 95 °C for 5 min under 1000 rpm shaking, followed by centrifugation at 
16000 g for 10 min at RT. Supernatant was processed immediately using FASP74 using 50 
μg of total protein as measured by QubitTM Protein Assay. Tryptic peptides were cleaned-
up using in-house produced C18-StageTips. Peptides were resuspended in 3% acetonitrile, 
0.1% formic acid in water including iRT standard peptides.
Data-independent acquisition (DIA) was performed on an Orbitrap Fusion Lumos mass 
spectrometer (Thermo Fisher Scientific, San Jose, CA) coupled online to an Acquity UPLC 
M-class (Waters, Milford, MA) using a PicoView 565 nanospray source (New Objective). 
Peptide mixtures were separated in a single-pump trap/elute mode, using a trapping 
(nanoEase Symmetry C18, 5 μm, 180 μm × 20 mm) and an analytical column (nanoEase 
HSS T3 C18, 100 Å, 1.8 μm, 75 μm x 250 mm). Solvent A was water, 0.1% formic acid and 
solvent B was acetonitrile, 0.1% formic acid. 0.5 μg peptides/sample were loaded with a 
constant flow of 0.5% solvent B, at 15 μL/min onto the trapping column. Trapping time was 
0.5 min. Peptides were eluted via the analytical column with a constant flow of 300 nL/min. 
During the elution step, the percentage of solvent B increased in a nonlinear fashion from 
8% to 22% in 82 min and 22% to 32% in 8 min. In brief, following MS settings were 
applied: MS1 scan at 120’000 Orbitrap resolution with an AGC target of 1 × 10^6 and max. 
injection time of 118 ms in the mass range of 350 to 1205 m/z, followed by 50 DIA scans 
covering a precursor mass range of 400 to 1000 m/z with isolation window widths of 12 m/z. 
The scan resolution in the Orbitrap was set to 15’000 with an AGC target of 1 × 10^6 and 
max. injection time of 25 ms. The HCD collision energy was set to 30%.
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In brief, raw files were analysed in Spectronaut Pulsar (13.9.191106.43655, Biognosys) by 
library-free DirectDIA. The basic principles of DirectDIA analysis have been previously 
described by75. The searches were done against the mouse reference proteome (UniProtKB/
Swiss-Prot) and a eGFP reference. Search results were filtered at 1% FDR on precursor and 
protein group level. Only the top 3 peptides were used for label-free protein intensity 
calculation. The protein group report of significant proteins was further used for plotting in 
R.
Functional gene set enrichment and network visualisation
All proteins identified previously were mapped to human STRING identifiers via the gene 
names and sequence similarity. Functional gene set enrichment was performed using the 
“Proteins with Values/Ranks” functionality in STRINGv1176 for each chromatin reader. The 
log2 fold changes over background were used. From all terms enriched in any of the 
chromatin readers, nine Gene Ontology Cellular Component terms (The Gene Ontology 
Consortium, 2019) which were significantly enriched in at least one of the readers were 
selected. Cytoscape (version 3.7.1) was used to layout the 79 proteins that were identified in 
ChromID experiments and are members of at least one of the selected GO terms. 
Visualisation was based on GO term membership only. Each protein was represented by a 
pie chart which signifies in which reader the protein was significantly detected after LS-
MS/MS. STRING interaction confidences were added as links between proteins, with a 
cutoff set at confidence 0.4. For foreground protein network visualisation, all proteins with a 
positive log2 fold change in any of the chromatin readers compared to nBASU were 
considered as foreground. Their protein-protein interaction network was retrieved from 
STRINGv1176 with an interaction confidence threshold of 0.7. The network was imported 
into Cytoscape (version 3.7.1) and visualized using the “Prefuse Force Directed OpenCL 
Layout”.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The protein complexes associated with specific chromatin marks in living cells are 
identified using engineered binding proteins.
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Figure 1. Nuclear and genomic localisation indicates correct eCR interactions with the genome
a) Top: chromatin reader domains used in this study and their specificities towards 
chromatin marks. Bottom: schematics of constructs utilised to generate mouse embryonic 
stem cells expressing engineered chromatin readers (eCRs). eCRs are composed of single or 
dual chromatin reader domains fused in frame to eGFP and a biotin acceptor site (see also 
Supplementary Fig. 1a). b) Recombinase-Mediated Cassette Exchange (RMCE) followed by 
double selection (Ganciclovir and Puromycin) was applied to generate stable integration of 
the expression construct at a defined site in the mouse genome. Stably expressed eCRs are in 
vivo biotinylated by a bacterial BirA ligase. c) Live imaging shows nuclear localisation of 
single and dual eCRs in mouse ES cells. Nuclear eGFP serves as control (See also 
Supplementary Fig. 2). Size bars = 5 μm. Similar results were obtained from 2 independent 
experiments. d-f) Genome browser examples showing correct localisation of eCRs 
according to chromatin modifications detected by antibody-ChIP-seq and DNA methylation 
by MeDIP-seq. For histone-PTM readers, only eCRs with two reader domains are shown 
(See supplementary Fig. 3 for single-domain eCRs). Shown is the library-normalised read 
density at 100bp intervals. Gene models and the position of CpG islands and repetitive 
elements are indicated. g) Pearson correlation score obtained from comparisons of eCRs 
with chromatin modifications at selected genomic intervals positive for the interrogated 
chromatin modifications (N=340291).
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Figure 2. Functional analysis indicates dependency on reader domains and modifications for 
correct eCR localisation.
a-b) Genome browser examples for loss of binding of mutant-eCRs to sites enriched by wild 
type eCRs. Shown is the library-normalised read density at 100bp intervals. Gene models 
and the position of CpG islands and repetitive elements are indicated. c) Genome browser 
example for loss of CBX7-2xChromo-eCR binding to the genome in absence of H3K27me3 
in Eed-KO cells. d) Box plots showing loss of binding of mutant eCRs to sites bound by 
their wild-type versions (CBX1 N=29879, CBX7 N=3204, MBD1 N=141443, MeCP2 
N=27176). In addition, removal of binding substrates such as DNA methylation (Dnmt-
TKO) or H3K27me3 (Eed-KO) results in loss of binding of wild-type eCRs to the 
corresponding sites. Shown are log2-FC enrichments at peak regions identified for the wild-
type eCRs in wild type cells. Boxes denote the interquartile range (IQR) and whiskers 1.5 x 
IQR. Median values are indicated. e) Heatmap showing the histone-PTM log2-FC 
enrichment scores obtained from CBX1-2xChromo and TAF3-2xPhd eCR ChIP. Histone-
PTMs are clustered based on enrichment scores. Colour code below the heatmap indicates 
histone isoforms and modification types detected in this assay. f-g) Dot plots showing 
enrichment/depletion for selected histone-PTMs, and the effect of combinatorial serine-10 
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phosphorylation on CBX1-2xChromo binding. Results from two independent measurements 
are shown.
Villaseñor et al. Page 26













Figure 3. ChromID identifies proteins associated with H3K9me3 and DNA methylation.
a) Schematic describing ChromID using engineered chromatin readers fused to promiscuous 
biotin ligases (BioL). b) Volcano plot showing ChromID results obtained using the CBX1-
eCR-BASU targeting H3K9me3 over a reader-free nuclear BASU (nBASU) control. 
Statistically-enriched proteins are indicated (FDR-corrected two-tailed t-test, FDR = 0.01, s0 
= 0.1, log2-FC > 0, n = 4 independent replicates). Peptides used to identify CBX1 match the 
Chromodomain used in the eCR. c) Bar plots representing the top 10 cellular component GO 
terms summarizing the proteins (N=58) enriched by CBX1-eCR-BASU. The combined 
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score is calculated by multiplying the ln(p-value) from Fisher's exact test (two-tailed) and 
the z-score. d) Heatmap representation of significantly enriched proteins captured with the 
5mC-reader (MBD1-eCR-BASU) and compared to results obtained using a mutant 5mC-
reader (R22A-eCR-BASU). Shown are average LFQ intensities (log2-FC) from four 
independent measurements. Peptides used to identify MBD1 match the MBD domain used 
in the eCR. e) Same as in c, but for proteins enriched by MBD1-eCR-BASU.
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Figure 4. Generation and validation of eCRs reading bivalent H3K4me3 and H3K27me3 marks.
a) Genome browser example showing context-dependent localisation of dual-reader eCRs to 
bivalent sites decorated by H3K4me3 and/or H3K27me3. Binding is preferentially directed 
to bivalent sites, while regions modified by H3K4me3- or H3K27me3-only show less 
recruitment. Gene models and the position of CpG islands and repetitive elements are 
indicated. b) Scatter plots indicating the distribution (highlighted data points) and 
enrichment (colour) for the tested eCRs along the mouse genome based on H3K27me3 
and/or H3K4me3 marks. Shown is the enrichment of H3K27me3 and H3K4me3 at 1kb 
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windows covering the entire genome (grey). Coloured data points indicate the top 1% 
genomic windows enriched by the indicated eCR. eCRs specific for one modification 
separate towards their respective substrates, while the dual reader localises predominantly to 
the bivalent-modified sites (See also Supplementary Fig. 11d). c) Average density profiles 
around H3K4me3- (red) and H3K27me3-monovalent (blue) or bivalent-peaks (black). Data 
indicates increased preference of the dual-reader eCR for the bivalent peaks while binding at 
H3K4me3- and H3K27me3-only peaks is strongly reduced (See also Supplementary Fig. 
11e).
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Figure 5. ChromID identifies the proteins associated with key chromatin marks in mouse ES 
cells.
a) Bar plots representing the top 10 cellular component GO terms enriched at H3K4me3-, 
H3K27me3- and bivalently-modified chromatin. b) Genome browser example for FLASH/
CASP8AP2 co-localising at transcribed histone genes marked with H3K4me3. c) Heatmap 
representation of proteins significantly-enriched in either of the ChromID experiments 
specific for H3K9me3-, H3K4me3-, H3K27me3- or bivalently-modified chromatin in mouse 
ES cells (FDR-corrected, two-tailed t-test, FDR = 0.01, n = 4 independent replicates). 
Significance threshold was set to s0 = 0.1 and FDR = 0.01. The LFQ intensities (log2-FC) 
over nBASU are shown. d) Network analysis based on proteins belonging to major cellular 
component GOs terms identified in at least one ChromID experiments (N proteins = 79). 
Individual proteins are shown as nodes, edges indicate interactions retrieved from the 
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STRING database (interaction score > 0.9). Proteins detected in ChromID experiments 
belonging to the selected GO terms, but not called significant by the two-tailed t-test are 
shown as grey nodes. Significantly enriched proteins are coloured according to the reader 
they have been identified. e) Heatmap representation of identified factors classified based on 
their functionality and clustered according to the computed LFQ intensities (log2-FC/
nBASU). Proteins were selected based on min 0.5 log2-FC in at least one ChromID 
experiment. TF: Transcription Factor.
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